US stock · US markets · public data

CRL

Charles River Laboratories International Inc · Healthcare

Reference price$357.27Updated according to the public source
P/E—
P/B6.00
ROE-7.52%
DY 12M0.00%
Net margin—
Net debt/equity—
Market capUS$ 17.2 B
Volume (shares)1,173,097
SectorHealthcare
Overview

About CRL

Demonstrações públicas consolidadas + SEC Company Facts

Charles River Laboratories International Inc (CRL) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: 2026.

Distributions

Dividends and distributions · last 12 records

public data

The source returned no recent distributions for this asset.

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

Available

Income statement

Account2023202420252026
Revenue$4,129,409,000.00$4,049,989,000.00$4,015,382,000.00—
Operating Income$617,261,000.00$227,347,000.00$25,162,000.00—
Net Income$480,370,000.00$25,291,000.00-$142,163,000.00—
EPS Diluted$9.22 / share$0.20 / share-$2.91 / share—

Balance sheet

Account2023202420252026
Total Assets$8,195,001,000.00$7,528,345,000.00$7,135,422,000.00—
Total Liabilities$4,536,003,000.00$4,020,267,000.00$3,924,228,000.00—
Total Equity$3,602,276,000.00$3,466,952,000.00$3,169,931,000.00—
Long-term Debt————
Current Debt$3,172,000.00$155,000.00$166,000.00—
Shares Outstanding50,985,527 shares51,349,770 shares51,141,607 shares49,227,800 shares
Cash & Investments————
Dívida Líquida————

Cash flow

Account2023202420252026
Operating Cash Flow$683,898,000.00$734,577,000.00$737,646,000.00—
Capital Expenditures$318,528,000.00$232,967,000.00$219,152,000.00—
Free Cash Flow$365,370,000.00$501,610,000.00$518,494,000.00—
FAQ

Frequently asked questions

What is the price of CRL?

The reference price available for CRL is $357.27.

What is the P/B of CRL?

The P/B of CRL is 6.00. This compares price with reported book value per share.

What is the ROE of CRL?

The ROE (Return on Equity) of CRL is -7.52%. This relates the reported net result to shareholders' equity.

What is the dividend yield of CRL?

The dividend yield of CRL is 0.00%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of CRL?

The market capitalization of CRL is US$ 17.2 B.

What sector is CRL in?

CRL operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.